non-clinical trial institute
Scope
Date
~
-
Machinery
Saudi Arabia partners with Korea's LS to spur non-petrochem sectors
South Korean conglomerate LS Group and the government of Saudi Arabia will jointly seek business opportunities in a number of non-petrochemical sect...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience start to deliver Novavax COVID-19 vaccine
South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Hydrogen economy
Korea Zinc to up sales to $19 billion by 2033 with green energy
Korea Zinc Inc., South Korea’s and the world’s largest lead and zinc smelter, will accelerate its drive to foster its new growth engines...
Dec 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean to develop submarine technology to evade detection
South Korea's Hanwha Ocean Co. has consecutively secured contracts for naval technology-related vessel research projects. The company recently annou...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Research & Development
POSCO to build 2nd N.EX.T Hub research institute in Seongnam city
POSCO Group, which owns South Korea’s largest steelmaker, plans to build a second research institute near Seoul to support the conglomerate&rs...
Nov 02, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Korean games
NCSOFT to unveil 7 new titles in global lineup at G-STAR 2023 game show
NCSOFT Corp., a major South Korean game developer and publisher, said on Tuesday it will showcase seven new titles in its upcoming global lineup at ...
Oct 17, 2023 (Gmt+09:00)
-
Carbon neutrality
Hyundai Glovis pledges carbon neutrality by 2045
South Korean shipping and logistics company Hyundai Glovis Co. on Thursday pledged to achieve carbon neutrality by 2045. Despite producing a h...
Oct 06, 2023 (Gmt+09:00)
-
Banking & Finance
Korean banks go digital in Southeast Asia for non-interest gains
South Korea’s top four banks are strengthening their overseas operations, particularly in the digital banking business, to increase their non-...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HMM embarks on biofuel ship pilot testing on global route
South Korea has begun a pilot operation of a biofuel-powered container ship on a global route, the government said on Friday. HMM Co.'s container sh...
Sep 15, 2023 (Gmt+09:00)
-
Batteries
Young Poong, AJ Networks to form battery recycling chain in Europe
South Korea’s non-ferrous metal company Young Poong Co. has teamed up with AJ Networks to establish a secondary batteries resource circulation...
Sep 15, 2023 (Gmt+09:00)
-
Energy
Hyundai E&C, Poland bolster partnerships in nuclear power
Hyundai Engineering & Construction Co., a major affiliate of South Korean automaker Hyundai Motor Co., is boosting its networks in the nuclear p...
Sep 14, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
KOREA Investment Week
Celltrion builds clinical data bank for new biosimilars
The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Artificial intelligence
KT, Vector Institute to cooperate for hyperscale AI
South Korea's KT Corp. announced on Wednesday that it has been in talks with Canada's Vector Institute to explore collaborative opportunities in the...
Sep 06, 2023 (Gmt+09:00)
-
ESG
LG Group manages ESG information like financial data
LG Group has decided to manage environmental, social, and governance (ESG) management activities as if they were financial data. The aim is to provi...
Sep 01, 2023 (Gmt+09:00)
-
Real estate
S.Korean lenders in New York luxury hotel likely to see losses
Some South Korean institutional investors may see significant losses on their investment in a hotel in the heart of New York as the developer has de...
Aug 29, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to participate in S.Korea’s new drug project
South Korea's JW Pharmaceutical announced on Monday that its experimental hair loss drug, JW0061, has been selected for a two-year funding program b...
Aug 28, 2023 (Gmt+09:00)